Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation - PubMed (original) (raw)
. 2003 Oct 31;278(44):43001-7.
doi: 10.1074/jbc.M307869200. Epub 2003 Aug 21.
Affiliations
- PMID: 12933797
- DOI: 10.1074/jbc.M307869200
Free article
Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation
Jiyun Yoo et al. J Biol Chem. 2003.
Free article
Abstract
Transforming growth factor-beta (TGF-beta)-dependent apoptosis is important in the elimination of damaged or abnormal cells from normal tissues in vivo. In this report, we identify GADD45b as an effector of TGF-beta-induced apoptosis. GADD45b has been shown to be a positive mediator of apoptosis induced by certain cytokines and oncogenes. We show that Gadd45b is an immediateearly response gene for TGF-beta and that the proximal Gadd45b promoter is activated by TGF-beta through the action of Smad2, Smad3, and Smad4. We show that ectopic expression of GADD45b in AML12 murine hepatocytes is sufficient to activate p38 and to trigger apoptotic cell death, whereas antisense inhibition of Gadd45b expression blocks TGF-beta-dependent p38 activation and apoptosis. Furthermore, we also show that TGF-beta can activate p38 and induce apoptosis in mouse primary hepatocytes from wild-type mice, but not from Gadd45b-/- mice. All of these findings suggest that GADD45b participates in TGF-beta-induced apoptosis by acting upstream of p38 activation.
Similar articles
- Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F. Ungefroren H, et al. J Biol Chem. 2005 Jan 28;280(4):2644-52. doi: 10.1074/jbc.M411925200. Epub 2004 Nov 16. J Biol Chem. 2005. PMID: 15546867 - The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview.
Shen XY, Shi SH, Li H, Wang CC, Zhang Y, Yu H, Li YB, Liu B. Shen XY, et al. Front Mol Neurosci. 2022 Oct 13;15:1021207. doi: 10.3389/fnmol.2022.1021207. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311022 Free PMC article. Review.
Cited by
- Deciphering CD59: Unveiling Its Role in Immune Microenvironment and Prognostic Significance.
Patel B, Silwal A, Eltokhy MA, Gaikwad S, Curcic M, Patel J, Prasad S. Patel B, et al. Cancers (Basel). 2024 Nov 1;16(21):3699. doi: 10.3390/cancers16213699. Cancers (Basel). 2024. PMID: 39518137 Free PMC article. - Involvement of mitogen- and stress-activated protein kinase 1 in BMP-6-induced chondrocyte differentiation.
Nakano N, Tashiro E, Shimada T, Ebisawa M, Kojima S, Ayabe K, Yamamoto Y, Maeda S, Itoh F, Itoh S. Nakano N, et al. J Biol Chem. 2024 Sep 21;300(11):107806. doi: 10.1016/j.jbc.2024.107806. Online ahead of print. J Biol Chem. 2024. PMID: 39307301 Free PMC article. - Nono induces Gadd45b to mediate DNA repair.
Mamontova V, Trifault B, Burger K. Mamontova V, et al. Life Sci Alliance. 2024 Jun 6;7(8):e202302555. doi: 10.26508/lsa.202302555. Print 2024 Aug. Life Sci Alliance. 2024. PMID: 38843934 Free PMC article. - Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.
Danielpour D. Danielpour D. Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533. Pharmaceuticals (Basel). 2024. PMID: 38675493 Free PMC article. Review. - TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J. Deng Z, et al. Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w. Signal Transduct Target Ther. 2024. PMID: 38514615 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous